PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jan-2026 MDaudit Recognized as One of Modern Healthcare's Best in Business ACCESS Newswire
12-Jan-2026 Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity ACCESS Newswire
12-Jan-2026 CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia ACCESS Newswire
12-Jan-2026 Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million ACCESS Newswire
12-Jan-2026 IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship Network Site, in Richmond, Virginia ACCESS Newswire
12-Jan-2026 US Med-Equip Recognized as One of Modern Healthcare's Best in Business ACCESS Newswire
12-Jan-2026 ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue ACCESS Newswire
12-Jan-2026 ChemWerth Appoints New General Sales Manager To Increase Its Generic API Footprint in India Businesswire
12-Jan-2026 VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital ACCESS Newswire
12-Jan-2026 Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City ACCESS Newswire
12-Jan-2026 GridAI: The Grid Is the New Battleground for AI Economics ACCESS Newswire
12-Jan-2026 Ozempic Face and Loose Skin Surge Drives DMV Patients to The Naderi Center's Advanced Non-Surgical & Surgical Treatments ACCESS Newswire
12-Jan-2026 Black Book Research Releases 2026 State of South Korean Acute Care EMR Digital Adoption Report ACCESS Newswire
12-Jan-2026 OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC ACCESS Newswire
12-Jan-2026 Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference ACCESS Newswire
12-Jan-2026 Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound ACCESS Newswire
12-Jan-2026 Monthly Update December - A Year of Breakthroughs, Expansion and International Consolidation ACCESS Newswire
12-Jan-2026 CelLBxHealth PLC Announces Board Changes ACCESS Newswire
12-Jan-2026 Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Businesswire
11-Jan-2026 Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome Businesswire